A resistance gene that allows bacteria to beat an important class of antibiotics has started to appear in microorganisms taken from Midwestern patients, according to researchers at Washington University School of Medicine in St. Louis.
Less than a decade ago, scientists first noticed the BlaKPC gene in bacteria taken from East Coast patients. They found bacteria with an active copy of the gene could defeat carbapenems, a relatively young family of antibiotics that works on a wide variety of bacteria. Physicians generally reserve carbapenems for use in the most critically ill patients.
The new study, presented this week in Chicago at the Interscience Conference on Antimicrobial Agents and Chemotherapy, is among the first to detect the resistance gene in samples taken from a Midwestern hospital.
Researchers found the gene in only four of 243 samples from 223 patients with bloodstream-based bacterial infections. But BlaKPC spreads easily among bacteria, and scientists found the method most hospitals use to check for resistance genes didn't detect all BlaKPC-positive strains.
"It's relatively easy for us to find this gene, but most hospitals don't have access to the same high-tech methods that we have at a major medical center," says senior author David Warren, M.D., assistant professor of medicine. "To help slow the spread of this gene, we need to look at whether we can develop a more effective way to detect it using widely available equipment and procedures."
BlaKPC was originally identified during an East Coast outbreak of the bacterium Klebsiella pneumoniae. The gene is encoded on a DNA structure known as a plasmid that can be easily copied and passed around not just among bacteria of the same species but also from one bacterial species to another. Subsequent studies found mortality rates climbing as high as 50 percent when bacteria with the resistance gene infected patients.
"We can't say much about BlaKPC's effects on mortality here yet, because we only had four patients test positive for bacteria containing the resistance gene," notes lead author Jonas Marschall, M.D., a fellow in infectious diseases.
Infection with a bacterium carrying an active copy of the resistance gene doesn't mean all treatment options are gone. But detection of BlaKPC can be key both to successful treatment and to containing the spread of the resistance gene by isolating affected patients.
To search for the BlaKPC gene, scientists used a technique known as PCR (for polymerase chain reaction) to isolate and amplify bacterial DNA. But most hospitals test for antibiotic resistance using a more low-tech method that involves directly exposing bacteria to antibiotics in the lab. When researchers used this method to look for BlaKPC-positive bacteria in their samples, it failed to catch all four strains carrying the gene.
This may be a result of the resistance gene being inactive in the bacteria. The gene does not convey its carbapenem-fighting abilities until the bacteria make a copy of its protein, and the bacterium may need some stimulus from the environment to start making those copies.
Regardless of whether the gene is spreading in active or inactive form, though, Warren asserts that clinicians need a better, more widely accessible method to track it.
Source: Washington University School of Medicine
Related stories:
Rapid test for pathogens developed by K-State researchers
Dangerous disease often spreads faster than it takes to diagnose it in the lab. To remedy that, researchers at Kansas State University have developed a test to bring that time from days down to hours.
Rifamycin antibiotics attack tuberculosis bacteria with walls, not signals
(PhysOrg.com) -- Amid concerns about the rising number of new tuberculosis cases worldwide, researchers led by Rockefeller University’s Seth A. Darst have reexamined and disproved a theory that describes how a potent class of antibiotics kills a deadly form of bacteria. The findings, which will appear in this week’s online issue of the
Proceedings of the National Academy of Sciences, not only bring scientists closer to understanding how these antibiotics work but also how the bacteria become resistant to their effects.
New antibiotic beats superbugs at their own game
The problem with antibiotics is that, eventually, bacteria outsmart them and become resistant. But by targeting the gene that confers such resistance, a new drug may be able to finally outwit them. Rockefeller University scientists tested the new drug, called Ceftobiprole, against some of the deadliest strains of multidrug-resistant Staphylococcus aureus (MRSA) bacteria, which are responsible for the great majority of staphylococcal infections worldwide, both in hospitals and in the community.
Thinking ahead: Bacteria anticipate coming changes in their environment
Microbes may be smarter than we think. A new study by Princeton University researchers shows for the first time that bacteria don't just react to changes in their surroundings -- they anticipate and prepare for them.
Thinking ahead: Bacteria anticipate coming changes in their environment
A new study by Princeton University researchers shows for the first time that bacteria don't just react to changes in their surroundings -- they anticipate and prepare for them. The findings, reported in the June 6 issue of
Science, challenge the prevailing notion that only organisms with complex nervous systems have this ability.
Possible new approach to purifying drinking water
A genetic tool used by medical researchers may also be used in a novel approach to remove harmful microbes and viruses from drinking water.
Important Plant Enzymes Identified
Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have identified enzymes important in the modification of isoflavonoids, natural plant products that help plants resist fungal infections, and may have beneficial health effects for humans as well. The research, which will be published online May 22, 2008, in
The Plant Journal, may pave the way for implanting the isoflavonoid-synthesis pathway into bioenergy crops to promote disease resistance and thereby prevent yield losses, and/or to enhance the production of other useful chemical feedstocks.
An ancient protein balances gene activity and silences foreign DNA in bacteria
Compared to humans, bacteria have a much tidier genome. The tiny microorganisms pack their genes closely together, and don’t carry around a lot of extraneous DNA, so-called junk DNA that fills in the gaps between genes. Some 90 percent of the complete genome sequence of the bacteria E. coli contains sequences of DNA that code for protein, while 90 percent of the human genome is non–coding junk DNA.